NexgenRx Inc. (TSXV: NXG)
Canada
· Delayed Price · Currency is CAD 0.250
0.00 (0.00%)
Dec 19, 2024, 9:30 AM EST
NexgenRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 29, 2024 | Dec '23 Dec 30, 2023 | Dec '22 Dec 30, 2022 | Dec '21 Dec 30, 2021 | Dec '20 Dec 30, 2020 | Dec '19 Dec 30, 2019 | 2018 - 2014 |
| Operating Revenue | 15.5 | 13.29 | 12.57 | 11.79 | 10.39 | 9.33 | Upgrade
|
| Other Revenue | 0.61 | 0.56 | 0.21 | 0.05 | 0.18 | 0.21 | Upgrade
|
| Revenue | 16.11 | 13.85 | 12.78 | 11.84 | 10.57 | 9.54 | Upgrade
|
| Revenue Growth (YoY) | 18.00% | 8.33% | 7.94% | 12.01% | 10.82% | 33.06% | Upgrade
|
| Cost of Revenue | 3.61 | 3.03 | 2.6 | 2.03 | 1.38 | 1.17 | Upgrade
|
| Gross Profit | 12.5 | 10.82 | 10.18 | 9.81 | 9.2 | 8.37 | Upgrade
|
| Selling, General & Admin | 10.72 | 9.62 | 8.43 | 6.18 | 6.49 | 7.27 | Upgrade
|
| Operating Expenses | 12.02 | 10.96 | 9.9 | 7.61 | 7.51 | 8.27 | Upgrade
|
| Operating Income | 0.48 | -0.14 | 0.29 | 2.2 | 1.69 | 0.09 | Upgrade
|
| Interest Expense | -0.07 | -0.03 | -0.02 | -0.06 | -0.21 | -0.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.13 | -0.13 | -0.13 | -0.13 | -0.14 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | 0.28 | -0.31 | 0.13 | 2.01 | 1.34 | -0.28 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.47 | - | Upgrade
|
| Pretax Income | 0.28 | -0.31 | 0.13 | 2.01 | 1.81 | -0.28 | Upgrade
|
| Income Tax Expense | 0.03 | 0.03 | 0.16 | -2.01 | -0.31 | -0.07 | Upgrade
|
| Net Income | 0.25 | -0.33 | -0.02 | 4.02 | 2.12 | -0.21 | Upgrade
|
| Net Income to Common | 0.25 | -0.33 | -0.02 | 4.02 | 2.12 | -0.21 | Upgrade
|
| Net Income Growth | - | - | - | 89.90% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 71 | 71 | 70 | 70 | 70 | 70 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 71 | 70 | 75 | 74 | 70 | Upgrade
|
| Shares Change (YoY) | 0.98% | 0.28% | -6.01% | 0.88% | 6.10% | 2.48% | Upgrade
|
| EPS (Basic) | 0.00 | -0.00 | -0.00 | 0.06 | 0.03 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | -0.00 | -0.00 | 0.05 | 0.03 | -0.00 | Upgrade
|
| EPS Growth | - | - | - | 86.21% | - | - | Upgrade
|
| Free Cash Flow | 1.24 | 1.2 | 0.68 | 3.7 | 2.53 | 0.99 | Upgrade
|
| Free Cash Flow Per Share | 0.02 | 0.02 | 0.01 | 0.05 | 0.03 | 0.01 | Upgrade
|
| Dividend Per Share | 0.010 | 0.010 | 0.010 | - | - | - | Upgrade
|
| Dividend Growth | 100.00% | 0% | - | - | - | - | Upgrade
|
| Gross Margin | 77.58% | 78.14% | 79.67% | 82.87% | 86.99% | 87.69% | Upgrade
|
| Operating Margin | 2.98% | -1.04% | 2.25% | 18.57% | 15.97% | 0.98% | Upgrade
|
| Profit Margin | 1.58% | -2.40% | -0.18% | 33.93% | 20.01% | -2.18% | Upgrade
|
| Free Cash Flow Margin | 7.68% | 8.67% | 5.30% | 31.23% | 23.95% | 10.43% | Upgrade
|
| EBITDA | 1.63 | 1.1 | 1.53 | 3.31 | 2.41 | 0.72 | Upgrade
|
| EBITDA Margin | 10.09% | 7.97% | 11.98% | 27.98% | 22.82% | 7.50% | Upgrade
|
| D&A For EBITDA | 1.15 | 1.25 | 1.24 | 1.11 | 0.72 | 0.62 | Upgrade
|
| EBIT | 0.48 | -0.14 | 0.29 | 2.2 | 1.69 | 0.09 | Upgrade
|
| EBIT Margin | 2.98% | -1.04% | 2.25% | 18.57% | 15.97% | 0.98% | Upgrade
|
| Effective Tax Rate | 9.08% | - | 116.66% | - | - | - | Upgrade
|
| Revenue as Reported | 16.11 | 13.85 | 12.78 | 11.84 | 11.04 | 9.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.